Payne Jake E, Chambers Richard, Liknaitzky Paul
Centre for Mental Health, Swinburne University of Technology, Melbourne, Victoria 3122, Australia.
Mindfulness Programs, Monash University, Melbourne, Victoria 3800, Australia.
ACS Pharmacol Transl Sci. 2021 Mar 16;4(2):416-423. doi: 10.1021/acsptsci.1c00034. eCollection 2021 Apr 9.
Psychedelic and mindfulness interventions have been shown to improve mental ill-health and wellbeing, with a range of clinical processes and effects in common. However, each appear to contain specific challenges in the context of mental health treatment. In this Perspective, we focus on a set of distinct affordances, "useful differences", within psychedelic and mindfulness interventions that might address common challenges within the other intervention. Accordingly, we propose a set of applied synergies, indicating specific ways in which these two promising interventions might be combined for greater benefit. Metaphorically, on the journey toward mental health and wellbeing, we propose that psychedelic treatments may serve the role of Compass (initiating, motivating, and steering the course of mindfulness practice), with mindfulness interventions serving the role of Vehicle (integrating, deepening, generalizing, and maintaining the novel perspectives and motivation instigated by psychedelic experience). We outline a set of testable hypotheses and future research associated with the synergistic action of psychedelic and mindfulness interventions toward improved clinical outcomes.
迷幻剂和正念干预已被证明可改善心理健康问题并增进幸福感,它们有一系列共同的临床过程和效果。然而,在心理健康治疗背景下,每种干预似乎都存在特定挑战。在本观点文章中,我们聚焦于迷幻剂和正念干预中一组独特的特性,即“有益差异”,这些差异或许能应对另一种干预中的常见挑战。因此,我们提出了一系列应用协同作用,指明了这两种有前景的干预措施可如何结合以带来更大益处。打个比方,在通往心理健康和幸福的旅程中,我们认为迷幻剂治疗可能起到指南针的作用(启动、激发并引导正念练习的进程),而正念干预则起到交通工具的作用(整合、深化、推广并维持由迷幻体验引发的新观点和动力)。我们概述了一组与迷幻剂和正念干预协同作用以改善临床结果相关的可检验假设和未来研究方向。